Scripps Research scientists found that HIV vaccination can lead to the production of anti-immune complex antibodies (blue) that recognize immune complexes composed of antibodies (green ...

spurring the production of new antibodies, including some that bind to existing immune complexes on the virus' surface. In a series of follow-up experiments on HIV-vaccinated animals, Brown ...

spurring the production of new antibodies, including some that bind to existing immune complexes on the virus' surface. In a series of follow-up experiments on HIV-vaccinated animals, Brown ...

For example, an antibody that can recognise an antigen on the Salmonella bacterium will not recognise an antigen on the HIV virus. Scientists discovered that we can make antibodies to bind to ...

An additional immune response occurs, spurring the production of new antibodies, including some that bind to existing immune complexes on the virus’ surface. In a series of follow-up experiments on ...

N6 is a newly discovered antibody at NIAID. It has evolved a unique mode of binding that depends less on a variable area of the HIV envelope known as the V5 region and focuses more on conserved ...

spurring the production of new antibodies, including some that bind to existing immune complexes on the virus’ surface. In a series of follow-up experiments on HIV-vaccinated animals ...

Get Instant Summarized Text (Gist) An HIV vaccine candidate has been developed that effectively guides immune cells to evolve into broadly neutralizing antibodies (bnAbs). In mouse studies, the ...

Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) recently discovered a human neutralizing antibody, 10E8, that binds to the GP41 protein of HIV-1 and prevents ...